Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial-Reference-Cited by-全球学者库

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Published:2018-11 Issue:11 Volume:6 Page:863-873
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Yue Dongsheng,Xu Shidong,Wang Qun,Li Xiaofei,Shen Yi,Zhao Heng,Chen Chun,Mao Weimin,Liu Wei,Liu Junfeng,Zhang Lanjun,Ma Haitao,Li Qiang,Yang Yue,Liu Yongyu,Chen Haiquan,Wang Changli

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference28 articles.

1. Adjuvant chemotherapy for surgically resected non-small cell lung cancer;Heon;J Thorac Cardiovasc Surg,2012

2. Adjuvant chemotherapy for resected non-small cell lung cancer;Wakelee;Semin Thorac Cardiovasc Surg,2008

3. Postoperative adjuvant systemic therapy in completely resected non-small-cell lung cancer: a systematic review;Bradbury;Clin Lung Cancer,2017

4. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer;Burdett;Cochrane Database Syst Rev,2015

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis;European Journal of Clinical Pharmacology;2024-02-01

2. A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study;Radiation Oncology;2024-01-22

3. Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non–Small Cell Lung Cancer;Cancer Research and Treatment;2024-01-15

4. Efficacy of Adjuvant First-Generation TKIs versus Chemotherapy in Patients with Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis;Cancer Investigation;2024-01-15

5. Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous- cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis;2024-01-15